Life sciences real estate has matured from a Boston/Cambridge and San Francisco / South Bay duopoly into a genuine NYC metro market. The growth is driven by Manhattan's anchor research institutions (NYU Langone, Mount Sinai, Memorial Sloan Kettering, Rockefeller, Weill Cornell), the Cornell Tech and SUNY public-private collaborations, and a maturing biotech VC ecosystem.
NYC Metro Lab Demand Picture
Manhattan lab demand concentrates around the anchor institutions: Alexandria Real Estate Equities has been the dominant developer (Alexandria Center for Life Science at 26th & FDR, expansion plans for the East River campus). University City Bioworks is growing. NYC EDC and SUNY Downstate are co-investing in the LifeSciNYC initiative — a $1B public-private program for lab and incubator space across the five boroughs.
Brooklyn and Long Island Growth
Outside Manhattan, growth is fastest at Brooklyn Navy Yard (NYU's Tandon, Industry City), Long Island City (Cornell Tech's Tata Innovation Center spillover), and the Long Island corridor (Cold Spring Harbor Lab, Brookhaven National Lab, Stony Brook University, Northwell Health). The LI corridor offers more accessible building costs ($800-$1,400/SF for lab vs $1,400-$2,200/SF in Manhattan) and better proximity to GMP manufacturing.
Lab vs GMP Distinctions
Tenant demand splits into wet lab (basic research, R&D — typical 25-40% of building SF), GMP manufacturing (FDA-regulated production — typical floor-to-floor heights 18-22 feet, dedicated MEP), and office for science (clinical trial managers, regulatory affairs — standard Class A office). Lab buildings command premium rents ($90-$160/SF in Manhattan, $50-$90/SF in Brooklyn / Long Island) vs Class A office.
- Lab and GMP development requires specialized MEP engineering — coordinate the consultant team early.
- NYC EDC and SUNY-affiliated programs offer building subsidies for qualifying life sciences projects.
- Anchor institutional tenants drive sub-market dynamics; track university real estate moves carefully.
- Skyline maintains active mandates from life sciences operators seeking NYC metro acquisition or lease space.
Robert Khodadadian and Skyline Properties broker NYC commercial real estate including buildings being repositioned for life sciences use. The firm has closed $976M+ in NYC commercial real estate. Email info@skylineprp.com for confidential life sciences advisory.